Infection Protection for Clinician and Patient
Welcome to AseptiScope™
We provide Infection Protection for Clinician & Patient with novel aseptic solutions. If you are a clinician, we are dedicated to making infection control fast and simple. If you are a patient, we are here to protect you. We are driven to bring innovative and validated solutions that lower the risk of contamination and infection in healthcare systems.
The DiskCover™ System, our flagship product, is an evidence-based solution for the longstanding, unaddressed, and increasingly prominent threat of stethoscope contamination.
In addition to the DiskCover System, a broader line of infection prevention innovations are in development. Subscribe and follow AseptiScope for ongoing updates!
Leadership
Scott W. Mader
Founder & Chief Executive Officer
Alan S. Maisel, MD
Founder & Chief Clinical Officer
W. Frank Peacock MD
Founder & Chief Medical Officer
Kelly M. Powers
Founder & Chief Operating Officer
Tom Watlington
Chief Commercial Officer
Scientific advisors
William T. Abraham, MD
Bruno R. Cotter, MD
Stuart Kipper, MD
Peter A. McCullough, MD, MPH
Sean-Xavier Neath, MD, PhD
Mitul Patel, MD, FACC, FSCAI
Dr. Bhupinder Singh, MD, FASN, FNKF, FCRS
Martin Than, MD
Francesca Torriani, MD
Stewart Turner, PhD
Alpesh Amin, MD, MBA, MACP, SFHM, FACC, FRCP (Lond)
Commercial advisors
John A. Butterfield
Steve Daly
Jim Edmondson
Lauren Lehman
William Longacre
Roger C. Mader
Steve Mitchell
Media and events
Press releases
News regarding AseptiScope, the DiskCover System, and stethoscope contamination is increasingly visible in the clinical community. The prevalence of poor stethoscope hygiene and resultant contamination reveal significant gaps in infection prevention that the DiskCover System will help to address.
New Study in Mayo Clinic Proceedings Shows AseptiScope DiskCover™ Barriers…
2021/01/19Clostridioides difficile (C. difficile) is a leading cause of healthcare associated infections in the USA, contributing to nearly 500,000 infections, 30,000 deaths, and $4.8B in annual excess acute care costs1 C. difficile is impervious to current standard-of-care cleaning with alcohol Study found zero growth of C. difficile inoculated stethoscopes protected with AseptiScope disk cover barriers…
New Mayo Clinic Proceedings Study Finds Single Use Barriers Clinically…
2021/01/11Auscultations using professional stethoscopes with disk cover barriers from AseptiScope resulted in 100% diagnostic accuracy and no loss of sound amplitude Auscultations employing disposable stethoscopes produced an overall error rate of nearly 11% in clinical diagnosis Compared to disposable stethoscopes, disk cover barriers from AseptiScope are cost-effective, clinically superior, and physician-preferred January 11, 2021…
INVESTORS
AseptiScope is a privately held company with funding and support from a network of investors. The organization is strategically positioned to introduce novel and innovative technology aimed at Infection Prevention for Clinician & Patient. Its flagship product takes aim at healthcare-associated infections, specifically stethoscope contamination, and the significant risks to patients, healthcare workers, and healthcare systems. The company’s DiskCover System is technology that disrupts the traditional patient examination by stethoscope with a highly visible and effective infection barrier – filling a technology gap that is widened by the COVID-19 pandemic. There is currently no other automated, touch-free, and clinically proven system available to the healthcare community.